Sep 4, 2014

Novartis drug probe falls short

The Tokyo criminal probe into the manipulation of clinical data pertaining to the efficacy of a Novartis Pharma-marketed drug for blood pressure has failed to unravel the whole picture of the scandal.

Novartis drug's data-tampering reflects unchecked collusion

| Jan 13, 2014

Novartis drug's data-tampering reflects unchecked collusion

by Tomoko Otake

Last week, the Health, Labor and Welfare Ministry filed a criminal complaint with prosecutors against Novartis Pharma K.K., the Japanese subsidiary of Swiss pharmaceutical giant Novartis, alleging the firm made exaggerated advertising claims for its blockbuster blood pressure drug Diovan. The ministry alleges the ...

Jan 8, 2014

Ministry targets Novartis claims for legal action

The health ministry is making final arrangements to file a criminal complaint with prosecutors against Novartis Pharma K.K. over alleged exaggerated advertising for a blood pressure-lowering drug in violation of the pharmaceutical affairs law, ministry officials said Wednesday. The Health, Labor and Welfare Ministry ...

Dec 18, 2013

Novartis false ad complaint planned

The health ministry is planning to file a criminal complaint against Novartis Pharma K.K. over alleged use of false advertising for its Diovan blood pressure-lowering drug, officials said Wednesday. Kyoto Prefectural University of Medicine and Tokyo-based Jikei University School of Medicine have found that ...

Another study report on Novartis drug found inappropriate

Oct 31, 2013

Another study report on Novartis drug found inappropriate

Shiga University of Medical Science on Thursday became the third Japanese institution to conclude that a clinical study report on Novartis Pharma K.K.’s Diovan blood pressure-lowering drug contained doubtful data and was inappropriate. A Novartis Pharma employee’s participation in the clinical study on the ...

Oct 19, 2013

Remedies for rigged research

It still isn't clear who manipulated clinical research data in favor of Novartis Pharma's blood-pressure drug Diovan, casting a cloud on the credibility of Japan's medical universities.

Jul 30, 2013

No drug data manipulation: Novartis

Novartis Pharma K.K. said Monday it could find no evidence a former employee manipulated or altered clinical research data for the drugmaker’s Diovan blood pressure-lowering drug. Although Kyoto Prefectural University of Medicine said earlier the data had been manipulated, a third-party investigation has found ...

Jul 29, 2013

Health ministry probes Diovan skin disruption reports

The health ministry is investigating reports of skin problems linked to the use of Diovan, Novartis Pharma K.K.’s popular drug for reducing high blood pressure, sources familiar with the matter said Monday. After probing reports that skin sores occur after taking the drug, the ...

Data in Novartis drug study manipulated

Jul 12, 2013

Data in Novartis drug study manipulated

The data used in a clinical study on Novartis Pharma K.K.’s blockbuster blood pressure drug Diovan were manipulated, Kyoto Prefectural University of Medicine has revealed. The research, based on around 3,000 Japanese with high blood pressure, was started in 2004 by Hiroaki Matsubara, a ...